Baoyuan decoction inhibits atherosclerosis progression through suppression peroxidized fatty acid and Src/MKK4/JNK pathway-mediated CD 36 expression
Phytomedicine · 2024-07 · 130 · 155668
DOI: 10.1016/j.phymed.2024.155668 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2024-07. Verfasst von Zhen Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Hauptthemen laut MEDLINE: Atherosclerosis, CD36 Antigens, Drugs, Chinese Herbal, Foam Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Baoyuan decoction (BYD) has been widely utilized as a traditional prescription for the treatment of various conditions such as coronary heart disease, aplastic anemia, and chronic renal failure. However, its potential efficacy in improving atherosclerosis has not yet been investigated. PURPOSE: Our research aimed to assess the potential of BYD as an inhibitor of atherosclerosis and uncover the underlying mechanism by which it acts on foam cell formation. STUDY DESIGN AND METHODS: High-fat diet-induced ApoE-/- mice were employed to explore the effect of BYD on atherosclerosis. The differential metabolites in feces were identified and analyzed by LC-Qtrap-MS. In addition, we utilized pharmacological inhibition of BYD on foam cell formation induced by oxLDL in THP-1 cells to elucidate the underlying mechanisms specifically in macrophages. RESULTS: The atherosclerotic plaque burden in the aortic sinus of ApoE-/- mice was notably reduced with BYD treatment, despite no significant alterations in plasma lipids. Metabolomic analysis revealed that BYD suppressed the increased levels of peroxidized fatty acids, specifically 9/13-hydroxyoctadecadienoic acid (9/13-HODE), in the feces of mice. As a prominent peroxidized fatty acid found in oxLDL, we confirmed that 9/13-HODE induced the overexpression of CD36 in THP-1 macrophages by upregulating PPARγ. In subsequent experiments, the decreased levels of CD36 triggered by oxLDL were observed after BYD treatment. This decrease occurred through the regulation of the Src/MMK4/JNK pathway, resulting in the suppression of lipid deposition in THP-1 macrophages. CONCLUSIONS: These results illustrate that BYD exhibits potential anti-atherosclerotic effects by inhibiting CD36 expression to prevent foam cell formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
- Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: drlj666@163.com.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: pengfeitu@163.com.
- Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: zj98v2@163.com.
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wu, Z., Wang, L., Yin, Z., Gao, Y., Song, Y., Ma, J., Zhao, M., Wang, J., Xue, W., Pang, X., Zhao, Y., Li, J., Tu, P., & Zheng, J. (2024). Baoyuan decoction inhibits atherosclerosis progression through suppression peroxidized fatty acid and Src/MKK4/JNK pathway-mediated CD 36 expression. Phytomedicine, 130, 155668. https://doi.org/10.1016/j.phymed.2024.155668
Vancouver
Wu Z, Wang L, Yin Z, Gao Y, Song Y, Ma J, et al. Baoyuan decoction inhibits atherosclerosis progression through suppression peroxidized fatty acid and Src/MKK4/JNK pathway-mediated CD 36 expression. Phytomedicine. 2024;130:155668. doi:10.1016/j.phymed.2024.155668
BibTeX
@article{Wu2024,
author = {Wu, Zhen and Wang, Lingxiao and Yin, Ziyu and Gao, Yun and Song, Yuelin and Ma, Jiale and Zhao, Maoyuan and Wang, Junjiao and Xue, Weigang and Pang, Xueping and Zhao, Yunfang and Li, Jun and Tu, Pengfei and Zheng, Jiao},
title = {Baoyuan decoction inhibits atherosclerosis progression through suppression peroxidized fatty acid and Src/MKK4/JNK pathway-mediated CD 36 expression},
journal = {Phytomedicine},
year = {2024},
volume = {130},
pages = {155668},
doi = {10.1016/j.phymed.2024.155668}
}
EUVIMED